SCHEMBL4906828

SCHEMBL4906828

CCOC(=O)c1cn(CC)c2ccc(OCc3ccccc3)cc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
TSHR P16473 2/20 0.56
HPGD P15428 2/20 0.56
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 1/20 0.56
RAB9A P51151 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LTB4R Q15722 2/20 0.55
LTB4R2 Q9NPC1 2/20 0.55
MAPK1 P28482 1/20 0.54
NMT1 P30419 4/20 0.53
MAOB P27338 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HSP90AA1 P07900 1/20 0.52
NMT2 O60551 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
TDP1 Q9NUW8 1/20 0.51
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4181154 0.92 TSHR (0.57) LMNATSHRALDH1A1LTB4RLTB4R2
SCHEMBL25494597 0.86 LMNA (0.59) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL27670763 0.84 LMNA (0.67) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL3816761 0.84 LMNA (0.67) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL3816295 0.81 LMNA (0.76) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL7284037 0.81 LMNA (0.76) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL3975004 0.81 ALDH1A1 (0.51) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL4908153 0.80 LMNA (0.62) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL7285360 0.80 LMNA (0.77) LMNATSHRHPGDALDH1A1KDM4E
SCHEMBL3819876 0.80 LMNA (0.64) LMNATSHRHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249033-A1 Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections GLAXOSMITHKLINE ISTRAZIVACKI CENTER ZAGREB D.O.O. (HR) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249033-A1 Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections CYP51A1, CUTA, MALT1 LMNA 3497/4885TSHR 2055/4885HPGD 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.